Investing Profile

Chris Garabedian

InvestorVC
CEO, Xontogeny and Portfolio Manager, PXV Fund
perceptivelife.com/team/Boston, Massachusetts
Photo of Chris Garabedian, Investor at Perceptive Advisors
Your Intro Paths to Chris Garabedian

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →

Find Chris Garabedian on

cb
Current Investing Position
Perceptive Advisors Investor
Investment Range
$100K - $10.0M
Sweet Spot
$1M
Investments On Record
21

Chris Garabedian is on these Sector & Stage Rankings

Chris Garabedian's Investments On Record (15)

CompanyStageDateRound SizeTotal Raised
Zucara Therapeutics
Series BNov 2024$20M
Series AMar 2020$21M
$41M
Marea Therapeutics
Series BJun 2024$190M
$260M
Co-investors: Maha Katabi (Sofinnova Investments), Aaron Royston (venBio), Charles Homcy (Third Rock Ventures), Jeffrey Tong (Third Rock Ventures)
CereVasc
Series BMay 2024$70M
Series AJun 2020$44M
$110M
Delve Bio
Series AJun 2023$35M
$35M
Peroxitech Therapeutics
Series ADec 2022$25M
SeedMay 2021
$25M
Tellus Therapeutics
Series ADec 2022$35M
SeedMay 2021$2M
$37M
PolyCore Therapeutics
SeedApr 2022
$500K
VivoSense
Series AMar 2022$25M
$25M